V2X, Inc. is showcasing its latest defense technologies at the 2026 Association of the United States Army (AUSA) Annual Meeting, including the Tempest Sentinel Counter-UAS system, AI-driven Cold Steel predictive maintenance platform, integrated Advantor security solutions, and Gateway Mission Router for enhanced air-to-ground communications. These innovations aim to improve protection against drone threats, optimize aircraft readiness, secure critical assets, and enhance battlefield connectivity. This demonstration highlights V2X's commitment to advancing military readiness and operational efficiency through cutting-edge technology.
V2X's advanced technology showcase is the context for this Industrials-sector snapshot on Pluang. For readers following Industrials, here is Pluang's market snapshot as of Oct 06, 2026 18:13 WIB: Out of 93 priced US Industrials stocks, 65 rose and 22 fell. Notable movers include Symbotic Inc (SYM) at USD 43.44 with a 1-day change of +1.33% and Pluang order activity showing 89% Buy, Upwork Inc (UPWK) at USD 8.25 down 1.32% with 60% Sell activity, and GE Vernova Inc (GEV) at USD 1,003.00 up 1.31% with 75% Buy activity.
Morgan Stanley analyst Bob Huang lowered American International Group's (AIG) price target to $80 from $81, with the stock trading around $76, indicating potential upside. AIG is set to report its Q3 2026 earnings on November 3, with investors focuse...
Vertiv Holdings, a maker of power and cooling equipment for data centers, faces mixed analyst opinions with GLJ Research rating it a "Sell" and BMO Capital giving an "Outperform" rating. Despite a recent stock pullback, the company reported a 241% in...
Apogee Enterprises reported strong fiscal Q2 results with adjusted earnings of $1.17 per share, nearly double the estimated $0.59, and revenue of $391.14 million, surpassing expectations of $362.6 million. This marks a continued trend of beating esti...
McKesson received a bullish price target of $977 from Morgan Stanley, suggesting a 6.7% upside from its current price of $915.45. The company agreed to acquire Option Care Health for $32.05 per share, valuing the deal at approximately $5.8 billion in...
Ameriprise Financial has authorized an additional $5.5 billion for share repurchases through September 2028, supported by $2.1 billion in excess capital and $2.8 billion in liquidity. The company returned $1.9 billion to shareholders in H1 2026, incl...
